Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
391.00    6.00 (1.56%)
Bid:
387.00
Ask:
390.00
Spread: 3.00 (0.775%)
Market Cap: £499.46m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Director/PDMR Shareholding

21 May 2012 10:46

RNS Number : 7412D
North Atlantic Smlr Co Inv Tst PLC
21 May 2012
Β 

ο»Ώ

Annex DTR3

Β 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility and Connected Persons

Β 

Β 

All relevant boxes should be completed in block capital letters.

Β 

1.

Name of the issuer

Β 

NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

Β 

2.

State whether the notification relates to (i) a

transaction notified in accordance with DTR 3.1.2 R,

(ii) a disclosure made in accordance

LR 9.8.6R(1) or

(iii) a disclosure made in accordance with section 793 of the Companies Act (2006).

Β 

Β 

3.

Name of person discharging managerial

responsibilities/director

Β 

CHRISTOPHER HARWOOD BERNARD MILLS - DIRECTOR

4.

State whether notification relates to a person

connected with a person discharging managerial responsibilities/director named in 3 and identify the connected person

PURCHASE BY HARWOOD HOLDCO LIMITED, A COMPANY OWNED BY MR MILLS

5.

Indicate whether the notification is in respect of a holding of the person referred to in 3 or 4 above or in respect of a nonbeneficial

interest

Β 

BENEFICIAL

6.

Description of shares (including class), debentures or derivatives or financial instruments relating to shares

Β 

ORDINARY SHARES

Β 

7.

Name of registered shareholders(s) and, if more than one, the number of shares held by each of them

Β 

NOT DISCLOSED

8.

State the nature of the transaction

Β 

PURCHASE

9.

Number of shares, debentures or financial

instruments relating to shares acquired

2,500 SHARES

Β 

10.

Percentage of issued class acquired (treasury shares of that class should not be taken into account when calculating percentage)

NEGLIGIBLE

Β 

11.

Number of shares, debentures or financial

instruments relating to shares disposed

Β 

12.

Percentage of issued class disposed (treasury shares of that class should not be taken into account when calculating percentage)

Β 

Β 

13.

Price per share or value of transaction

Β 

950 PENCE PER SHARE

Β 

Β 

14.

Date and place of transaction

Β 

18 MAY 2012, LONDON

Β 

15.

Total holding following notification and total percentage holding following notification (any treasury shares should not be taken into account when calculating percentage)

Β 

3,251,499 ORDINARY SHARES (23.04%)

200,000 ORDINARY SHARES - NON BENEFICIAL

16.

Date issuer informed of transaction

Β 

18 MAY 2012

Β 

Β 

Β 

Β 

If a person discharging managerial responsibilities has been granted options by the issuer

complete the following boxes

Β 

17.

Date of grant

Β 

Β 

18.

Period during which or date on which exercisable

Β 

Β 

19.

Total amount paid (if any) for grant of the option

20.

Description of shares or debentures involved (class and number)

Β 

Β 

21.

Exercise price (if fixed at time of grant) or

indication that price is to be fixed at the time of exercise

Β 

Β 

22.

Total number of shares or debentures over which options held following notification

Β 

23.

Any additional information

Β 

24.

Name of contact and telephone number for queries

BONITA GUNTRIP - COMPANY SECRETARY

020 7747 5681

Β 

Β 

Name of authorised official of issuer responsible for making notification

Β 

Β 

BONITA GUNTRIP

COMPANY SECRETARY

21 MAY 2012

Β 

Β 

Β 

Notes: This form is intended for use by an issuer to make a RIS notification required by DR 3.3.

(1)

An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24.

(2)

An issuer making a notification in respect of a derivative relating the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24.

(3)

An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24.

(4)

An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24.

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
RDSKFLBLLEFZBBX
Date   Source Headline
14th Aug 202511:04 amRNSNet Asset Value(s)
6th Aug 20259:57 amRNSTransaction in Own Shares and TVR
15th Jul 20259:34 amRNSNet Asset Value(s)
7th Jul 20251:00 pmRNSTransaction in Own Shares and TVR
7th Jul 202511:34 amRNSTransaction in Own Shares and TVR
19th Jun 20259:51 amRNSTransaction in Own Shares nad TVR
13th Jun 20253:52 pmRNSNet Asset Value(s)
12th Jun 20251:50 pmRNSShare Split and Total Voting Rights
12th Jun 20251:46 pmRNSResult of AGM
9th Jun 202510:45 amRNSTransaction in Own Shares and TVR
2nd Jun 20251:15 pmRNSTransaction in Own Shares and TVR
30th May 202511:01 amRNSTransaction in Own Shares and TVR
27th May 20253:26 pmRNSTransaction in Own Shares and TVR
23rd May 20251:44 pmRNSCompany Secretary Change
16th May 20257:00 amRNSNet Asset Value(s)
15th May 20257:00 amRNSAnnual Financial Report & Notice of AGM
7th May 20257:00 amRNSFinal Results
16th Apr 20257:00 amRNSNet Asset Value(s)
3rd Apr 202510:35 amRNSTransaction in Own Shares and TVR
31st Mar 20259:44 amRNSTransaction in Own Shares and TVR
24th Mar 20259:13 amRNSTransaction in Own Shares and TVR
18th Mar 20253:15 pmRNSNet Asset Value(s)
3rd Mar 20252:17 pmRNSTransaction in Own Shares and TVR
27th Feb 20257:00 amRNSDividend Declaration
17th Feb 202512:49 pmRNSTransaction in Own Shares and TVR
14th Feb 20259:26 amRNSNet Asset Value(s)
10th Feb 202511:05 amRNSTransaction in Own Shares and TVR
15th Jan 202511:10 amRNSDirector Declaration
15th Jan 202511:01 amRNSDirector Declaration
15th Jan 202510:39 amRNSNet Asset Value(s)
12th Dec 20241:48 pmRNSNet Asset Value(s)
29th Nov 202411:57 amRNSTransaction in Own Shares
25th Nov 202410:10 amRNSTransaction in Own Shares
15th Nov 202410:57 amRNSNet Asset Value(s)
11th Nov 202410:30 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 20247:00 amRNSDirector/PDMR Shareholding
28th Oct 202411:50 amRNSNet Asset Value(s)
28th Oct 20247:00 amRNSDirector/PDMR Shareholding
14th Oct 20247:00 amRNSInvestor Presentation via Investor Meet Company
3rd Oct 202411:51 amRNSInvestment Update: Performance Chemicals
3rd Oct 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSHalf-year Report - Replacement
25th Sep 20247:00 amRNSHalf-year Report
13th Sep 20247:00 amRNSNet Asset Value(s)
14th Aug 202410:40 amRNSNet Asset Value(s)
26th Jul 202410:20 amRNSTransaction in Own Shares
25th Jul 202411:08 amRNSTransaction in Own Shares
23rd Jul 20247:00 amRNSTransaction in Own Shares
17th Jul 20243:35 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.